These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 35862218)
1. ARMC5-CUL3 E3 ligase targets full-length SREBF in adrenocortical tumors. Okuno Y; Fukuhara A; Otsuki M; Shimomura I JCI Insight; 2022 Aug; 7(16):. PubMed ID: 35862218 [TBL] [Abstract][Full Text] [Related]
2. Cullin 3 targets the tumor suppressor gene ARMC5 for ubiquitination and degradation. Cavalcante IP; Vaczlavik A; Drougat L; Lotfi CFP; Perlemoine K; Ribes C; Rizk-Rabin M; Clauser E; Fragoso MCBV; Bertherat J; Ragazzon B Endocr Relat Cancer; 2020 Apr; 27(4):221-230. PubMed ID: 32023208 [TBL] [Abstract][Full Text] [Related]
3. A novel germline ARMC5 mutation in a patient with bilateral macronodular adrenal hyperplasia: a case report. Liu Q; Tong D; Xu J; Yang X; Yi Y; Zhang D; Wang L; Zhang J; Zhang Y; Li Y; Chang L; Chen R; Guan Y; Yi X; Jiang J BMC Med Genet; 2018 Mar; 19(1):49. PubMed ID: 29587644 [TBL] [Abstract][Full Text] [Related]
4. ARMC5 is part of an RPB1-specific ubiquitin ligase implicated in adrenal hyperplasia. Lao L; Bourdeau I; Gagliardi L; He X; Shi W; Hao B; Tan M; Hu Y; Peng J; Coulombe B; Torpy DJ; Scott HS; Lacroix A; Luo H; Wu J Nucleic Acids Res; 2022 Jun; 50(11):6343-6367. PubMed ID: 35687106 [TBL] [Abstract][Full Text] [Related]
5. ARMC5 mutations are common in familial bilateral macronodular adrenal hyperplasia. Gagliardi L; Schreiber AW; Hahn CN; Feng J; Cranston T; Boon H; Hotu C; Oftedal BE; Cutfield R; Adelson DL; Braund WJ; Gordon RD; Rees DA; Grossman AB; Torpy DJ; Scott HS J Clin Endocrinol Metab; 2014 Sep; 99(9):E1784-92. PubMed ID: 24905064 [TBL] [Abstract][Full Text] [Related]
6. Macronodular adrenal hyperplasia due to mutations in an armadillo repeat containing 5 (ARMC5) gene: a clinical and genetic investigation. Faucz FR; Zilbermint M; Lodish MB; Szarek E; Trivellin G; Sinaii N; Berthon A; Libé R; Assié G; Espiard S; Drougat L; Ragazzon B; Bertherat J; Stratakis CA J Clin Endocrinol Metab; 2014 Jun; 99(6):E1113-9. PubMed ID: 24601692 [TBL] [Abstract][Full Text] [Related]
7. Molecular and clinical evidence for an ARMC5 tumor syndrome: concurrent inactivating germline and somatic mutations are associated with both primary macronodular adrenal hyperplasia and meningioma. Elbelt U; Trovato A; Kloth M; Gentz E; Finke R; Spranger J; Galas D; Weber S; Wolf C; König K; Arlt W; Büttner R; May P; Allolio B; Schneider JG J Clin Endocrinol Metab; 2015 Jan; 100(1):E119-28. PubMed ID: 25279498 [TBL] [Abstract][Full Text] [Related]
8. The role of oxidative stress, glucocorticoid receptor and ARMC5 in lipid metabolism. Okuno Y; Fukuhara A; Shimomura I Endocr J; 2024 Jun; ():. PubMed ID: 38925988 [TBL] [Abstract][Full Text] [Related]
9. New pathogenic variants in ARMC5 gene in a series of Italian patients affected by primary bilateral macronodular adrenocortical hyperplasia (PBMAH). Giacché M; Panarotto A; Mori L; Poliani PL; Lanzi R; Lena MS; Castellano M Mol Genet Genomic Med; 2023 Apr; 11(4):e2126. PubMed ID: 36727580 [TBL] [Abstract][Full Text] [Related]
10. Do patients with incidentally discovered bilateral adrenal nodules represent an early form of ARMC5-mediated bilateral macronodular hyperplasia? Emms H; Tsirou I; Cranston T; Tsagarakis S; Grossman AB Endocrine; 2016 Sep; 53(3):801-8. PubMed ID: 27306888 [TBL] [Abstract][Full Text] [Related]